Physician profile
Alexandra E Settles
NPI 1932702727
$4,705.19
in general payments reported to CMS, 2019-2025
33 companies · $2,162 in 2025
The $2,162 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $653 · 2024: $1,890 · 2025: $2,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,605 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,605.20 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,192.94 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $771.69 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $551.40 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $312.77 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $252.45 | 2024-2025 | Veozah, Vyloy |
| Amgen INC. | $239.92 | 2023-2025 | Otezla, Repatha, Evenity |
| Shield Therapeutics INC | $183.93 | 2023-2025 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $165.02 | 2024 | |
| Aimmune Therapeutics, INC. | $113.41 | 2024-2025 | Zenpep |
| Pfizer INC. | $110.61 | 2023-2025 | |
| Exact Sciences Corporation | $80.09 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.89 | 2024-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.05 | 2023-2025 | Xifaxan, Trulance |
| Dexcom, INC. | $62.18 | 2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $60.06 | 2024-2025 | Voquezna |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $47.56 | 2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $42.36 | 2024-2025 | Capvaxive, Gardasil 9 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.80 | 2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $37.88 | 2025 | Trintellix |
| Penumbra, INC. | $33.76 | 2025 | Indigo System |
| Harmony Biosciences LLC | $28.39 | 2024 | |
| Corcept Therapeutics | $24.43 | 2024 | Korlym |
| Gilead Sciences, INC. | $24.17 | 2024 | Epclusa |
| Renalytix Ai, INC. | $23.98 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Axonics, INC. | $23.35 | 2024 | Axonics |
| Saluda Medical Americas, INC. | $21.04 | 2024 | Evoke |
| Inspire Medical Systems, INC. | $20.79 | 2025 | Inspire |
| Acella Pharmaceuticals, LLC | $19.75 | 2024 | NP Thyroid 60 |
| Vanda Pharmaceuticals INC. | $17.18 | 2023 | Hetlioz |
| Glaxosmithkline, LLC. | $17.09 | 2023 | Trelegy Ellipta |
| Lucid Diagnostics INC. | $16.60 | 2024 | |
| Idorsia Pharmaceuticals US INC | $15.31 | 2024 | Quviviq |
| Insulet Corporation | $14.34 | 2023 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Settles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.